Antibiotic resistance has led to the development of so-called “superbugs” that no longer respond to the current treatment modalities. The array of antibiotics available to treat these infections is dwindling with very few antibiotics in the pipeline. This article discussed the pathogens the Centers for Disease Control and Prevention (CDC) has placed in their urgent category: (1) Clostridium difficile, (2) Carbapenem-resistant Enterobacteriaceae, and (3) Neisseria gonorrhoeae. In addition, a few suggestions for prevention of resistance are offered.
NeuHC. The crisis in antibiotic resistance. Science. 1992;257(5073):1064-1073.
2.
DemainALSanchezS. Microbial drug discovery: 80 years of progress. J Antibiot. 2009;62:5-16.
3.
SchmidEFSmithDARyderSW. Communicating the risk and benefit of medicines. Drug Discov Today. 2007;12:355-364.
4.
TleyjehIMBin AbdulhakAARiazM. Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS ONE. 2012;7:e50836.
5.
FrancisMBAllenCAShresthaRSorgJA. Bile acid recognition by the clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog. 2013;9:e1003356.
6.
LittleMLQinXZerrDMWeissmanSJ. Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae. Int J Antimicrob Agents. 2012;39(1):52-57. doi:10.1016/j.ijantimicag.2011.09.014.
